Revizinone

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRevizinone
Drug Alias NameR-79595 (no stereochemistry)R-80122R-80123 (Z-isomer)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 3 inhibitors
TargetsPhosphodiesterase 3
Therapy Area/IndicationsMyocardial IschemiaHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson
Active IndicationsN/A
Inactive IndicationsMyocardial IschemiaHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A